Πλοήγηση ανά Συγγραφέα "Papandreou, C. N."
-
NEUTRAL ENDOPEPTIDASE (NEP) AND ENDOTHELIN 1 (ET-1) ARE INVERSELY EXPRESSED IN HORMONE-NAIVE PROSTATE CANCER AND ARE PREDICTORS OF BIOCHEMICAL FAILURE FROM RADICAL PROSTATECTOMY
Vlachostergios, P. J.; Patrikidou, A.; Kakkas, G.; Moutzouris, G.; Voutsadakis, I. A.; Karasavvidou, F.; Daliani, D. D.; Koukoulis, G.; Melekos, M. D.; Papandreou, C. N. (2010) -
Optimal chemotherapy for prostate cancer
Papandreou, C. N. (2004) -
p53 and Cyclooxygenase-2 Expression are Directly Associated with Cyclin D1 Expression in Radical Prostatectomy Specimens of Patients with Hormone-Naive Prostate Cancer
Vlachostergios, P. J.; Karasavvidou, F.; Patrikidou, A.; Voutsadakis, I. A.; Kakkas, G.; Moutzouris, G.; Zintzaras, E.; Daliani, D. D.; Melekos, M. D.; Papandreou, C. N. (2012)Prostate cancer (PCa) is a potentially curable disease when diagnosed in early stages and subsequently treated with radical prostatectomy (RP). However, a significant proportion of patients tend to relapse early, with the ... -
Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer
Vlachostergios, P. J.; Gioulbasanis, I.; Ghosh, S.; Tsatsanis, C.; Papatsibas, G.; Xyrafas, A.; Hatzidaki, E.; Vasiliou, C.; Kamposioras, K.; Agelaki, S.; Margioris, A. N.; Nasi, D.; Georgoulias, V.; Papandreou, C. N. (2013)Cancer patients usually develop malnutrition which may alter their innate immune system integrity. The aim of this study was to investigate the clinical relevance of chemokine response after lipopolysaccharide (LPS)-stimulation ... -
Preliminary evidence of efficacy and tolerance for weekly intravenous bortezomib plus mitoxantrone in patients with advanced androgen-independent prostate cancer (AIPCa)
Siefker-Radtke, A. O.; Poulter, V.; Mathew, P.; Tu, S. M.; Logothetis, C. J.; Papandreou, C. N. (2005) -
The proteasome as a target for cancer treatment: Focus on bortezomib
Papandreou, C. N. (2005)Targeted degradation of key regulatory proteins is an essential element of cell-cycle control. The proteasome plays a pivotal role in the degradation of such proteins and has, therefore, become an important therapeutic ... -
The role of ubiquitin-proteasome system in glioma survival and growth
Vlachostergios, P. J.; Voutsadakis, I. A.; Papandreou, C. N. (2013)High-grade gliomas represent a group of aggressive brain tumors with poor prognosis due to an inherent capacity of persistent cell growth and survival. The ubiquitin-proteasome system (UPS) is an intracellular machinery ... -
Selecting for predisposition to cancer cachexia
Gioulbasanis, I.; Vlachostergios, P. J.; Papandreou, C. N. (2012) -
The shaping of invasive glioma phenotype by the ubiquitin-proteasome system
Vlachostergios, P. J.; Voutsadakis, I. A.; Papandreou, C. N. (2013)Protein degradation is an indispensable process for cells which is often deregulated in various diseases, including malignant conditions. Depending on the specific cell type and functions of expressed proteins, this ... -
Targeting neuroendocrine prostate cancer: Molecular and clinical perspectives
Vlachostergios, P. J.; Papandreou, C. N. (2015)Neuroendocrine prostate carcinoma, either co-present with the local adenocarcinoma disease or as a result of transdifferentiation later in time, was described as one major process of emerging resistance to androgen deprivation ... -
The ubiquitin-proteasome system in glioma cell cycle control
Vlachostergios, P. J.; Voutsadakis, I. A.; Papandreou, C. N. (2012)A major determinant of cell fate is regulation of cell cycle. Tight regulation of this process is lost during the course of development and progression of various tumors. The ubiquitin-proteasome system (UPS) constitutes ...